APO RESEARCH · REPORT
GMP Cytokines
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
Product & engineering
Understand the product.
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Selected research
Industry Research
GMP Cytokines Industry Research Report 2026
Market perspective
Cytokines are a large group of small signalling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well.
GMP Cytokines are intended for use in GMP manufacturing of investigational or marketed clinical products, such as cell therapy, gene therapy, tissue-engineered products and other fields.
Global key players of GMP Cytokines include Bio-Techne, PeproTech, CellGenix, Miltenyi Biotec, Cytiva and Lonza, etc. Top three players occupy for a share about 46%. North America is the largest market, with a share about 54%, followed by Europe and Asia-Pacific. In terms of product, Growth Factor is the largest segment, with a share over 55%. In terms of application, Cell/Gene Therapy is the largest market, with a share over 54%.
Read the full market overview
Report Scope
This report quantifies the global GMP Cytokines market in terms of revenue (US$ million) and, where applicable, sales volume (mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/mg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
GMP Cytokines Market by Company
Miltenyi Biotec
Bio-Techne
Cytiva
Lonza
CellGenix
ReproCELL
PeproTech
Sino Biological
Creative Bioarray
Akron Biotech
Almog
GMP Cytokines Segment by Type
TNF
Interleukin
Growth Factor
Others
GMP Cytokines Segment by Application
Cell/Gene Therapy
Tissue-Engineered Products
Others
GMP Cytokines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Cytokines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Cytokines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Cytokines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of GMP Cytokines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of GMP Cytokines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of GMP Cytokines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- TNF
- Interleukin
- Growth Factor
- Others
Applications
- Cell/Gene Therapy
- Tissue-Engineered Products
- Others
Companies covered
- Miltenyi Biotec
- Bio-Techne
- Cytiva
- Lonza
- CellGenix
- ReproCELL
- PeproTech
- Sino Biological
- Creative Bioarray
- Akron Biotech
- Almog
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global GMP Cytokines Market Size (2021-2032)
- 2.2.2 Global GMP Cytokines Sales (2021-2032)
- 2.2.3 Global GMP Cytokines Market Average Price (2021-2032)
- 2.3 GMP Cytokines by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 TNF
- 2.3.3 Interleukin
- 2.3.4 Growth Factor
- 2.3.5 Others
- 2.4 GMP Cytokines by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cell/Gene Therapy
- 2.4.3 Tissue-Engineered Products
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global GMP Cytokines Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global GMP Cytokines Sales (mg) of Manufacturers (2021-2026)
- 3.3 Global GMP Cytokines Revenue of Manufacturers (2021-2026)
- 3.4 Global GMP Cytokines Average Price by Manufacturers (2021-2026)
- 3.5 Global GMP Cytokines Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of GMP Cytokines, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of GMP Cytokines, Product Type & Application
- 3.8 Global Manufacturers of GMP Cytokines, Established Date
- 3.9 Global GMP Cytokines Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Miltenyi Biotec
- 4.1.1 Miltenyi Biotec Company Information
- 4.1.2 Miltenyi Biotec Business Overview
- 4.1.3 Miltenyi Biotec GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Miltenyi Biotec GMP Cytokines Product Portfolio
- 4.1.5 Miltenyi Biotec Recent Developments
- 4.2 Bio-Techne
- 4.2.1 Bio-Techne Company Information
- 4.2.2 Bio-Techne Business Overview
- 4.2.3 Bio-Techne GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bio-Techne GMP Cytokines Product Portfolio
- 4.2.5 Bio-Techne Recent Developments
- 4.3 Cytiva
- 4.3.1 Cytiva Company Information
- 4.3.2 Cytiva Business Overview
- 4.3.3 Cytiva GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Cytiva GMP Cytokines Product Portfolio
- 4.3.5 Cytiva Recent Developments
- 4.4 Lonza
- 4.4.1 Lonza Company Information
- 4.4.2 Lonza Business Overview
- 4.4.3 Lonza GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Lonza GMP Cytokines Product Portfolio
- 4.4.5 Lonza Recent Developments
- 4.5 CellGenix
- 4.5.1 CellGenix Company Information
- 4.5.2 CellGenix Business Overview
- 4.5.3 CellGenix GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CellGenix GMP Cytokines Product Portfolio
- 4.5.5 CellGenix Recent Developments
- 4.6 ReproCELL
- 4.6.1 ReproCELL Company Information
- 4.6.2 ReproCELL Business Overview
- 4.6.3 ReproCELL GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 ReproCELL GMP Cytokines Product Portfolio
- 4.6.5 ReproCELL Recent Developments
- 4.7 PeproTech
- 4.7.1 PeproTech Company Information
- 4.7.2 PeproTech Business Overview
- 4.7.3 PeproTech GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 PeproTech GMP Cytokines Product Portfolio
- 4.7.5 PeproTech Recent Developments
- 4.8 Sino Biological
- 4.8.1 Sino Biological Company Information
- 4.8.2 Sino Biological Business Overview
- 4.8.3 Sino Biological GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sino Biological GMP Cytokines Product Portfolio
- 4.8.5 Sino Biological Recent Developments
- 4.9 Creative Bioarray
- 4.9.1 Creative Bioarray Company Information
- 4.9.2 Creative Bioarray Business Overview
- 4.9.3 Creative Bioarray GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Creative Bioarray GMP Cytokines Product Portfolio
- 4.9.5 Creative Bioarray Recent Developments
- 4.10 Akron Biotech
- 4.10.1 Akron Biotech Company Information
- 4.10.2 Akron Biotech Business Overview
- 4.10.3 Akron Biotech GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Akron Biotech GMP Cytokines Product Portfolio
- 4.10.5 Akron Biotech Recent Developments
- 4.11 Almog
- 4.11.1 Almog Company Information
- 4.11.2 Almog Business Overview
- 4.11.3 Almog GMP Cytokines Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Almog GMP Cytokines Product Portfolio
- 4.11.5 Almog Recent Developments
5 Global GMP Cytokines Market Scenario by Region
- 5.1 Global GMP Cytokines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global GMP Cytokines Sales by Region: 2021-2032
- 5.2.1 Global GMP Cytokines Sales by Region: 2021-2026
- 5.2.2 Global GMP Cytokines Sales by Region: 2027-2032
- 5.3 Global GMP Cytokines Revenue by Region: 2021-2032
- 5.3.1 Global GMP Cytokines Revenue by Region: 2021-2026
- 5.3.2 Global GMP Cytokines Revenue by Region: 2027-2032
- 5.4 North America GMP Cytokines Market Facts & Figures by Country
- 5.4.1 North America GMP Cytokines Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America GMP Cytokines Sales by Country (2021-2032)
- 5.4.3 North America GMP Cytokines Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe GMP Cytokines Market Facts & Figures by Country
- 5.5.1 Europe GMP Cytokines Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe GMP Cytokines Sales by Country (2021-2032)
- 5.5.3 Europe GMP Cytokines Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific GMP Cytokines Market Facts & Figures by Country
- 5.6.1 Asia Pacific GMP Cytokines Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific GMP Cytokines Sales by Country (2021-2032)
- 5.6.3 Asia Pacific GMP Cytokines Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America GMP Cytokines Market Facts & Figures by Country
- 5.7.1 South America GMP Cytokines Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America GMP Cytokines Sales by Country (2021-2032)
- 5.7.3 South America GMP Cytokines Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa GMP Cytokines Market Facts & Figures by Country
- 5.8.1 Middle East and Africa GMP Cytokines Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa GMP Cytokines Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa GMP Cytokines Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global GMP Cytokines Sales by Type (2021-2032)
- 6.1.1 Global GMP Cytokines Sales by Type (2021-2032) & (mg)
- 6.1.2 Global GMP Cytokines Sales Market Share by Type (2021-2032)
- 6.2 Global GMP Cytokines Revenue by Type (2021-2032)
- 6.2.1 Global GMP Cytokines Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global GMP Cytokines Revenue Market Share by Type (2021-2032)
- 6.3 Global GMP Cytokines Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global GMP Cytokines Sales by Application (2021-2032)
- 7.1.1 Global GMP Cytokines Sales by Application (2021-2032) & (mg)
- 7.1.2 Global GMP Cytokines Sales Market Share by Application (2021-2032)
- 7.2 Global GMP Cytokines Revenue by Application (2021-2032)
- 7.2.1 Global GMP Cytokines Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global GMP Cytokines Revenue Market Share by Application (2021-2032)
- 7.3 Global GMP Cytokines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 GMP Cytokines Value Chain Analysis
- 8.1.1 GMP Cytokines Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 GMP Cytokines Production Mode & Process
- 8.2 GMP Cytokines Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 GMP Cytokines Distributors
- 8.2.3 GMP Cytokines Customers
9 Global GMP Cytokines Analyzing Market Dynamics
- 9.1 GMP Cytokines Industry Trends
- 9.2 GMP Cytokines Industry Drivers
- 9.3 GMP Cytokines Industry Opportunities and Challenges
- 9.4 GMP Cytokines Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst